Literature DB >> 19690816

[Quality of life in dysphonia].

F Rosanowski1, E Grässel, U Hoppe, V Köllner.   

Abstract

Quality of life is multidimensional and comprises physical, emotional, and social aspects. It has always been the implicit focus of medical work. However, since the 1980s it has been possible to measure it explicitly. Quality of life is impaired in dysphonic patients; this finding is supported by specific studies on self-reported physical, emotional, and social well-being. For practical application of these data, it is recommended to measure all three domains. From a therapeutic point of view, verbal intervention following the PLISSIT model (permission, limited information, special suggestions, intensive therapy) has been proven to enhance patient satisfaction. Therefore, this clinical procedure is recommended for routine application in dysphonic patients.

Entities:  

Mesh:

Year:  2009        PMID: 19690816     DOI: 10.1007/s00106-009-1970-8

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  22 in total

1.  A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques. Guideline elaborated by the Committee on Phoniatrics of the European Laryngological Society (ELS).

Authors:  P H Dejonckere; P Bradley; P Clemente; G Cornut; L Crevier-Buchman; G Friedrich; P Van De Heyning; M Remacle; V Woisard
Journal:  Eur Arch Otorhinolaryngol       Date:  2001-02       Impact factor: 2.503

Review 2.  [Management of mental health and primary care. Development and evaluation of a training program based on the PLISSIT approach].

Authors:  R Vauth; M Härter; F Hohagen; C Kemmerich; J M Herrmann; G Haag; J Nolte; W Niebling; G Stadtmüller; K Fritzsche; M Berger
Journal:  Nervenarzt       Date:  1999-01       Impact factor: 1.214

3.  [Grading of the Voice Handicap Index].

Authors:  E Grässel; U Hoppe; F Rosanowski
Journal:  HNO       Date:  2008-12       Impact factor: 1.284

4.  Validation of an instrument to measure voice-related quality of life (V-RQOL).

Authors:  N D Hogikyan; G Sethuraman
Journal:  J Voice       Date:  1999-12       Impact factor: 2.009

5.  Quality of life in dysphonic patients.

Authors:  Sylvia Krischke; Susan Weigelt; Ulrich Hoppe; Volker Köllner; Michael Klotz; Ulrich Eysholdt; Frank Rosanowski
Journal:  J Voice       Date:  2005-03       Impact factor: 2.009

6.  [Determination of subjective impairment in dysphonia. A methodological comparison].

Authors:  S Günther; T Rasch; M Klotz; U Hoppe; U Eysholdt; F Rosanowski
Journal:  HNO       Date:  2005-10       Impact factor: 1.284

7.  The quality of life impact of dysphonia.

Authors:  J A Wilson; I J Deary; A Millar; K Mackenzie
Journal:  Clin Otolaryngol Allied Sci       Date:  2002-06

8.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

9.  [Satisfaction of dysphonic patients with psychosomatic assessment and intervention].

Authors:  S Pülz; A Schützenberger; E Grässel; V Köllner; U Eysholdt; F Rosanowski
Journal:  HNO       Date:  2009-09       Impact factor: 1.284

10.  [Voice handicap in patients with organic and functional dysphonia].

Authors:  S Weigelt; S Krischke; M Klotz; U Hoppe; V Köllner; U Eysholdt; F Rosanowski
Journal:  HNO       Date:  2004-08       Impact factor: 1.284

View more
  2 in total

1.  Voice handicap index and voice-related quality of life in small laryngeal carcinoma.

Authors:  C Kasper; M Schuster; G Psychogios; J Zenk; A Ströbele; F Rosanowski; E Grässel; T Haderlein
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-07       Impact factor: 2.503

2.  Impact of Superparamagnetic Iron Oxide Nanoparticles on Vocal Fold Fibroblasts: Cell Behavior and Cellular Iron Kinetics.

Authors:  Marina Pöttler; Anna Fliedner; Eveline Schreiber; Christina Janko; Ralf Philipp Friedrich; Christopher Bohr; Michael Döllinger; Christoph Alexiou; Stephan Dürr
Journal:  Nanoscale Res Lett       Date:  2017-04-20       Impact factor: 4.703

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.